Replies to post #285208 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

PK data is objective and not meaningless, but a necessity.

What amounts to interesting, but meaningless until potentially confirmed by a controlled blinded trial is PR on efficacy from 6 patients.

I think Anavex have the sense not to do the same for an open label cohort of 3 patients regardless of how encouraging that data in isolation might look.